AKTX

Akari Therapeutics
AKTX

Overview Fund Activity

13 hedge funds and large institutions have $15.1M invested in Akari Therapeutics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HP
Hikari Power
Japan
+$561K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$80K
3
Morgan Stanley
Morgan Stanley
New York
+$52.7K
4
HNB
Huntington National Bank
Ohio
+$49K
5
Deutsche Bank
Deutsche Bank
Germany
+$23.5K

Top Sellers

1
DM
Deerfield Management
New York
-$2.36M
2
VC
Vivo Capital
California
-$1.12M
3
Millennium Management
Millennium Management
New York
-$605K
4
QF
QVT Financial
New York
-$531K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$11K
Name Holding Trade Value Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$3.05M – – –
NMC
2
NEA Management Company
Maryland
$2.78M – – –
DM
3
Deerfield Management
New York
$2.66M -$2.36M -19,230 -47%
VMI
4
VHCP Management II
New York
$2.62M – – –
VC
5
Vivo Capital
California
$2.12M -$1.12M -9,099 -34%
HP
6
Hikari Power
Japan
$929K +$561K +4,566 +152%
Millennium Management
7
Millennium Management
New York
$709K -$605K -4,929 -46%
Bank of Montreal
8
Bank of Montreal
Ontario, Canada
$123K +$80K +650 +186%
Morgan Stanley
9
Morgan Stanley
New York
$54K +$52.7K +429 +3,900%
HNB
10
Huntington National Bank
Ohio
$49K +$49K +400 New
Deutsche Bank
11
Deutsche Bank
Germany
$32K +$23.5K +195 +279%
UBS Group
12
UBS Group
Switzerland
$13K -$3.34K -28 -20%
QF
13
QVT Financial
New York
– -$531K -6,604 Closed
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
– -$11K -119 Closed